G protein coupled receptor dimerization: Implications in modulating receptor function

Journal of Molecular Medicine

Volumn 79, Issue 5-6, 2001, Pages 226-242

  Gomes, Ivone ^a   Jordan, Bryen A ^a   Gupta, Achla ^a   Rios, Carl ^a   Trapaidze, Nino ^a   Devi, Lakshmi A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Desensitization; Downregulation; Oligomerization; Opioids; Signal transduction

Indexed keywords

COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; METABOTROPIC RECEPTOR; RHODOPSIN; SECRETIN;

DIMERIZATION; DOWN REGULATION; HUMAN; IMMUNOPRECIPITATION; MOLECULAR CLONING; OLIGOMERIZATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIMERIZATION; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034937698     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090100219     Document Type: Review

References (120)

1. Molecular tinkering of G protein-coupled receptors: An evolutionary success
2. Expanding horizons for receptors coupled to G proteins: Diversity and disease
3. Locating ligand-binding sites in 7TM receptors by protein engineering
4. Structure and function of G protein-coupled receptors
5. Model systems for the study of seven-transmembrane-segment receptors
6. In vitro mutagenesis and the search for structure-function relationships among G-protein coupled receptors
7. Specificity of receptor-G protein interactions: Searching for the structure behind the signal
8. G protein-coupled receptors: Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition
9. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
10. Molecular basis of receptor/G-protein-coupling selectivity
11. Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: Structure-function relationship with special reference to the human VIP-1 receptor
12. Serpentine receptors for parathyroid hormone, calcitonin and extracellular calcium ions
13. Functional significance of oligomerization of G protein-coupled receptors
14. RAMPs regulate the transport and ligand specificity of he calcitonin-receptor-like receptor
15. Beta-adrenergic receptors: Evidence for negative cooperativity
16. Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes
17. Guanine nucleotide regulation of mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting
18. Muscarinic cholinergic receptors in embryonic chick heart: Interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist 3H-cis-methyldioxolane
19. Two affinity states of M1 muscarinic receptors
20. Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarinic receptors
21. 2 muscarinic receptors
22. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation
23. Identification and molecular characterization of m3 muscarinic receptor dimers
24. Dopamine D2 receptor dimers and receptor-blocking peptides
25. Towards understanding the glycoprotein hormone receptors
26. Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor
27. Increased biological activity of dimers of oxymorphone and enkephalin: Possible role of receptor-crosslinking
28. 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography
29. Molecular size of the human platelet a2-adrenergic receptor as determined by radiation inactivation
30. Target size analysis of opioid receptors. No difference between receptor types, but discrimination between two receptor states
31. Molecular size of opiate (enkephalin) receptors in neuroblastoma-glioma hybrid cells as determined by radiation inactivation analysis
32. Hydrodynamic parameters of opioid receptors from frog brain
33. Physical characterization of native opiate receptors. Additional information from detailed analysis of a radiation-inactivated receptor
34. Structure of the thyrotropin receptor and thyroid adenylate cyclase system as determined by target analysis
35. Characterization of the subunit structure of the thyrotropin receptor in the FRTL-5 rat thyroid cell line
36. Radiation inactivation (target size analysis) of the gonadotropin-releasing hormone receptor: Evidence for a high molecular weight complex
37. Molecular characterization of muscarinic receptor subtypes in bovine cerebral cortex by radiation inactivation and molecular exclusion h.p.l.c.
38. Muscarinic receptor size on smooth muscle cells and membranes
39. Binding of [3H] SKF 38393 to dopamine D-1 receptors in rat striatum in vitro: Estimation of receptor molecular size by radiation inactivation
40. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells
41. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2
42. Dopamine D2 receptor dimers in human and rat brain
43. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: Subunit assembly may explain high- and low-affinity agonist states
44. Involvement of the amino terminus of the B2 receptor in agonist-induced receptor dimerization
45. Covalent crosslinking of angiotensin II to its binding sites in rat adrenal membranes
46. High affinity angiotensin II receptors in myocardial sarcolemmal membranes. Characterization of receptors and covalent linkage of 125I-angiotensin II to a membrane component of 116:000 daltons
47. Physicochemical characterization of photoaffinity-labeled angiotensin II receptors
48. Hydrodynamic properties of the angiotensin II receptor from bovine adrenal zona glomerulosa
49. Solubilization and partial characterization of angiotensin II receptors from rat brain
50. Solubilization and characterization of adrenal and uterine angiotensin II receptors after photoaffinity labeling
51. Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method
52. Phosphorylation and palmitoylation of human D2L dopamine receptor in Sf9 cells
53. Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells
54. Specific antibody to the thyrotropin receptor identifies multiple receptor forms in membranes of cells transfixed with wild-type receptor complementary deoxyribonucleic acid: Characterization of their relevance to receptor synthesis, processing, structure, and function
55. Immunoprecipitation isolates multiple TSH receptor forms from human thyroid tissue
56. Biological actions of monoclonal luteinizing hormone/human chorionic gonadotropin receptor antibodies
57. 2-AR through receptor dimerization
58. Dimerization of the d opioid receptor: Implication for a role in receptor internalization
59. G-protein-coupled receptor heterodimerization modulates receptor function
60. Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells
61. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation
62. Truncated V2 vasopressin receptors as negative regulators of wild-type v2 receptor function
63. Cooperativity manifest in the binding properties of the cardiac muscarinic receptors
64. Ig-hepta, a novel member of the G protein-coupled hepta-helical receptor (GPCR) family that has immunoglobulin-like repeats in a long N-terminal extracellular domain and defines a new subfamily of GPCRs
65. 236
66. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro
67. Characterization of the dimerization of metabotropic glutamate receptors using an N-terminal truncation of mGluR1α
68. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)
69. Subtypes of the somatostatin receptor assemble as functional homo and heterodimers
70. Gonadotropin-releasing hormone receptor microaggregation
71. G-protein-coupled receptors function as oligomers in vivo
72. Selective modulation of wild type receptor functions by mutants of G-protein coupled receptors
73. +2 receptor: Effects on cell surface expression, dimerization and signal transduction
74. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function
75. Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
76. Kappa opioid receptor endocytosis by dynorphin peptides
77. Beta-adrenergic regulation of alpha2-adrenergic receptors in the central nervous system
78. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: Evidence for increased affinity and reduction in number of binding sites
79. Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus
80. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia
81. Receptor-receptor interactions as an integrative mechanism in nerve cells
82. Co-expression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein linked receptors
83. Delta-opioid receptor subtypes and cross-talk with mu-receptors
84. Selective modulation of morphine antinociception, but not development of tolerance, by delta receptor agonists
85. Modulation of the analgesic efficacy and potency of morphine by [D-Pen2, D-Pen5]enkephalin in mice
86. Morphine tolerance increases mu-noncompetitive delta binding sites
87. beta-FNA binds irreversibly to the opiate receptor complex: In vivo and in vitro evidence
88. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5]enkephalin: Further evidence for two mu-binding sites
89. BR2
90. B-receptor subtypes assemble into functional heteromeric complexes
91. B receptor function
92. B receptor
93. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed
94. GABAB receptors-the first 7TM heterodimers
95. Oligomerization of mu and delta opioid receptors
96. Heterodimerization of mu and delta opioid receptors: A role in opioid synergy
97. Oligomerization of opioid receptors with b2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
98. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
99. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
100. Expression, purification and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor
101. Structural basis of glutamate recognition by a dimeric metabotrophic glutamate receptor
102. Sequence specificity in the dimerization of transmembrane α-helices
103. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization
104. 2-adrenergic receptor that exploits the domain structure of G-protein coupled receptors
105. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method
106. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: A site-directed spin-labeling study
107. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: A site-directed spin labeling study
108. Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering
109. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor
110. Construction of a high affinity zinc switch in the kappa-opioid receptor
111. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F
112. Domain swapping in G-protein coupled receptors
113. 2-adrenergic receptors
114. 2-adrenergic receptors
115. Correlated mutations and residue contacts in proteins
116. Correlated mutations contain information about protein-protein interaction
117. A molecular mechanism for the cleavage of a disulfide bond as the primary function of agonist binding to G-protein-coupled receptors based on theoretical calculations supported by experiments
118. Ab Initio modeling and molecular dynamic stimulation of the alpha1b-adrenergic receptor activation
119. Theoretical study of the electrostatically driven step of receptor-G protein activation
120. G protein linked receptors: Pharmacological evidence for the formation of heterodimers